Terms: = Prostate cancer AND Ki-67 AND Clinical Outcome
22 results:
1. An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer.
Brönimann S; Pradere B; Karakiewicz P; Abufaraj M; Briganti A; Shariat SF
Expert Rev Mol Diagn; 2020 Aug; 20(8):841-850. PubMed ID: 32552088
[TBL] [Abstract] [Full Text] [Related]
2. Single-stranded DNA binding protein 2 expression is associated with patient survival in hepatocellular carcinoma.
Kim H; Kim Y; Chung Y; Abdul R; Sim J; Ahn H; Shin SJ; Paik SS; Kim HJ; Jang K; Choi D
BMC Cancer; 2018 Dec; 18(1):1244. PubMed ID: 30541499
[TBL] [Abstract] [Full Text] [Related]
3. ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.
Nastały P; Filipska M; Morrissey C; Eltze E; Semjonow A; Brandt B; Pantel K; Bednarz-Knoll N
Transl Res; 2019 Jan; 203():49-56. PubMed ID: 30287243
[TBL] [Abstract] [Full Text] [Related]
4. Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
Omari A; Nastały P; Stoupiec S; Bałabas A; Dąbrowska M; Bielińska B; Huss S; Pantel K; Semjonow A; Eltze E; Brandt B; Bednarz-Knoll N
Int J Cancer; 2019 Feb; 144(3):607-614. PubMed ID: 30265376
[TBL] [Abstract] [Full Text] [Related]
5. Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for prostate cancer.
Pollack A; Kwon D; Walker G; Khor LY; Horwitz EM; Buyyounouski MK; Stoyanova R
J Natl Cancer Inst; 2017 Feb; 109(2):1-8. PubMed ID: 28376214
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic prostate tissue biomarkers of potential clinical use.
Van der Kwast TH
Virchows Arch; 2014 Mar; 464(3):293-300. PubMed ID: 24487790
[TBL] [Abstract] [Full Text] [Related]
7. ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08.
Verhoven B; Yan Y; Ritter M; Khor LY; Hammond E; Jones C; Amin M; Bahary JP; Zeitzer K; Pollack A
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):317-23. PubMed ID: 23474109
[TBL] [Abstract] [Full Text] [Related]
8. Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment.
Keshari KR; Tsachres H; Iman R; Delos Santos L; Tabatabai ZL; Shinohara K; Vigneron DB; Kurhanewicz J
NMR Biomed; 2011 Jul; 24(6):691-9. PubMed ID: 21793074
[TBL] [Abstract] [Full Text] [Related]
9. Global levels of histone modifications predict prognosis in different cancers.
Seligson DB; Horvath S; McBrian MA; Mah V; Yu H; Tze S; Wang Q; Chia D; Goodglick L; Kurdistani SK
Am J Pathol; 2009 May; 174(5):1619-28. PubMed ID: 19349354
[TBL] [Abstract] [Full Text] [Related]
10. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract] [Full Text] [Related]
11. Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer.
Furukawa J; Miyake H; Takenaka A; Hara I; Fujisawa M
BJU Int; 2007 Aug; 100(2):310-4. PubMed ID: 17511772
[TBL] [Abstract] [Full Text] [Related]
12. prostate cancer with small-cell morphology: an immunophenotypic subdivision.
Petraki C; Vaslamatzis M; Petraki K; Revelos K; Alevizopoulos N; Papanastasiou P; Gregorakis A
Scand J Urol Nephrol; 2005; 39(6):455-63. PubMed ID: 16303720
[TBL] [Abstract] [Full Text] [Related]
13. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study.
Abdulkader I; Sánchez L; Cameselle-Teijeiro J; Gude F; Chávez JE; López-López R; Forteza J; Fraga M
Oncol Rep; 2005 Dec; 14(6):1527-31. PubMed ID: 16273250
[TBL] [Abstract] [Full Text] [Related]
14. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.
Manley S; Mucci NR; De Marzo AM; Rubin MA
Am J Pathol; 2001 Sep; 159(3):837-43. PubMed ID: 11549576
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract] [Full Text] [Related]
16. Apoptosis, mitosis, p53, bcl(2), ki-67 and clinical outcome in prostate carcinoma treated by androgen ablation.
Szende B; Romics I; Torda I; Bély M; Szegedi Z; Lovász S
Urol Int; 1999; 63(2):115-9. PubMed ID: 10592500
[TBL] [Abstract] [Full Text] [Related]
17. Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression.
Cheng L; Pisansky TM; Sebo TJ; Leibovich BC; Ramnani DM; Weaver AL; Scherer BG; Blute ML; Zincke H; Bostwick DG
Clin Cancer Res; 1999 Oct; 5(10):2820-3. PubMed ID: 10537347
[TBL] [Abstract] [Full Text] [Related]
18. Relationship of ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy.
Khoo VS; Pollack A; Cowen D; Joon DL; Patel N; Terry NH; Zagars GK; von Eschenbach AC; Meistrich ML; Troncoso P
Prostate; 1999 Nov; 41(3):166-72. PubMed ID: 10517874
[TBL] [Abstract] [Full Text] [Related]
19. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U
Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
[TBL] [Abstract] [Full Text] [Related]
20. Predictability of PSA failure in prostate cancer by computerized cytometric assessment of tumoral cell proliferation.
Diaz JI; Mora LB; Austin PF; Muro-Cacho CA; Cantor AB; Nicosia SV; Pow-Sang JM
Urology; 1999 May; 53(5):931-8. PubMed ID: 10223486
[TBL] [Abstract] [Full Text] [Related]
[Next]